Drug intelligence / Profile preview

JUVÉDERM Ultra Plus XC

Development stage
Unknown
Lead developer
Allergan
Modality
Hydrogel Systems → Drug Delivery Systems
Administration
Intradermal
01

Overview

JUVÉDERM Ultra Plus XC is a sterile, biodegradable, non-pyrogenic, viscoelastic injectable gel implant composed of cross-linked hyaluronic acid (HA) produced by Streptococcus species of bacteria and formulated at a concentration of 24 mg/mL with 0.3% w/w lidocaine in a physiologic buffer. It is indicated for injection into the mid to deep dermis for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. The addition of lidocaine provides local anesthesia to improve patient comfort during injection. The product temporarily restores volume and smooths facial lines by acting as a cushioning agent in the skin[3][6][8]. Developed primarily for aesthetic use in adults over 21 years old, it is FDA-approved for these indications[2][7].

Brand names
JUVÉDERM Ultra Plus XC
Other names
Juvederm Ultra Plus XC

Beyond the preview

Go deeper on JUVÉDERM Ultra Plus XC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on JUVÉDERM Ultra Plus XC.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call